Understanding the Neurochemical Basis of STN and GPi-DBS: A Human Microdialysis Study
Objective: Analyze the extracellular concentrations of GABA and glutamate in response to acute electrical stimulation during DBS surgery using samples obtained from STN, thalamus, GPi…Time To Access Deep Brain Stimulation Surgery for Movement Disorders: A Canadian Single Center Study
Objective: To assess barriers to accessing Deep Brain Stimulation (DBS), as a function of the time required for each step of the workup and how…The Role of a Social Worker in a Deep Brain Stimulation Multidisciplinary Team
Objective: To characterize the contribution of a social worker (SW) in selecting and managing patients for deep brain stimulation (DBS) surgery. Background: It is common…Early Outcomes Support use of a Remote Cross-Border Surgical Centre for Deep Brain Stimulation in Parkinson’s Disease
Objective: We describe the results of a unique cross border collaboration to deliver BDS for Parkinson's disease in Ireland. Background: Deep brain stimulation (DBS) of…Deep Brain Stimulation during pregnancy: A systematic review of the literature
Objective: We conducted a critical appraisal of the literature on pregnant patients using deep brain stimulation (DBS) in order to assess safety outcomes for maternal…Model-Based Gait Outcomes to Track Parkinson’s Disease Progression ?
Objective: To determine whether outcomes extracted from a gait model can serve as markers of symptoms and neurodegeneration progression in Parkinson’s disease (PD). Background: Longitudinal…Speech Biomarkers for Dysarthria in Parkinson’s Disease — Clinical Validation Across two Languages
Objective: To identify reliable speech biomarkers for assessing dysarthria in individuals with Parkinson's disease (PD) and ensuring their clinical validity across languages. Background: This study…Physical activity in patients with atypical parkinsonian syndromes – Collection of real-world data
Objective: To record mobility in everyday life of patients with MSA, PSP and IPD using sensor-technology over several days. Background: Even in the early disease…Speech Processing System for Parkinson’s Disease Using Mixed Reality
Objective: Our initiative aims to develop an integrated AR/MR platform for collecting diagnostic data and monitoring patients with neurodegenerative diseases using digital markers from registered…Novel Partial Gene Deletion in CaCNA1A Presenting with Gait Ataxia, Vertigo, and Abnormal Eye Movements
Objective: To report a partial gene deletion in CaCNA1A associated with ataxia. Background: CaCNA1A gene, located on chromosome 19p, encodes the alpha-1a subunit of the…
